Live from the NIH registry
Studies recruiting near Olympia right now
Top 25 of 229 recruiting studies, sorted by proximity — each links to its official registry page
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Tacoma, Washington (25.8 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Northwest Medical Specialties — Tacoma, Washington (25.8 mi)
· Sponsor: Hoffmann-La Roche
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Traumatic Brain Injury, Insomnia
N/A
Interventional 360 participants sought
Madigan Army Medical Center — Fort Lewis, Washington (14.8 mi)
· Sponsor: Johns Hopkins University
The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System
Chronic Pain, Musculoskeletal Pain
N/A
Interventional 608 participants sought
Madigan Army Medical Center — Tacoma, Washington (25.8 mi)
· Sponsor: Brooke Army Medical Center
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Northwest Medical Specialties, PLLC ( Site 0067) — Tacoma, Washington (25.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Lay-Delivered Behavioral Activation in Senior Centers
Depression
N/A
Interventional 288 participants sought
Pt Defiance Senior Center — Tacoma, Washington (25.8 mi)
· Sponsor: University of Washington
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Multicare Health System — Tacoma, Washington (25.8 mi)
· Sponsor: Novo Nordisk A/S
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 130 participants sought
Northwest Medical Specialties — Tacoma, Washington (25.8 mi)
· Sponsor: Hoffmann-La Roche
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
GI Alliance Tacoma — Tacoma, Washington (25.8 mi)
· Sponsor: Janssen Research & Development, LLC
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
MultiCare Cancer Institute — Tacoma, Washington (25.8 mi)
· Sponsor: Natera, Inc.
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi)
· Sponsor: Children's Oncology Group
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi)
· Sponsor: NRG Oncology
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic
Phase 3
Interventional 735 participants sought
Vista Oncology ( Site 5449) — Olympia, Washington (0.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy
Cervical Spine Degeneration, ACDF Surgery
N/A
Interventional 76 participants sought
Madigan Army Medical Center — Tacoma, Washington (25.8 mi)
· Sponsor: Vanderbilt University Medical Center
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
MultiCare Institute for Research & Innovation /ID# 255954 — Tacoma, Washington (25.8 mi)
· Sponsor: AbbVie
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi)
· Sponsor: PedAL BCU, LLC
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 380 participants sought
Northwest Medical Specialties Tacoma /ID# 276281 — Tacoma, Washington (25.8 mi)
· Sponsor: AbbVie
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Lung Carcinoma
N/A
Interventional 237 participants sought
South Puget Intertribal Planning Agency (SPIPA) — Shelton, Washington (15.4 mi)
· Sponsor: Fred Hutchinson Cancer Center
Investigating Medical Massage Therapy for Patients With Sub-Acute Lower Back Pain
Lower Back Pain, Subacute Lower Back Pain
N/A
Interventional 220 participants sought
Madigan Army Medical Center — Joint Base Lewis McChord, Washington (15.7 mi)
· Sponsor: The Geneva Foundation
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Franciscan Heart and Vascular Associates — Tacoma, Washington (25.8 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
GI Alliance Tacoma — Tacoma, Washington (25.8 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Tacoma, Washington (25.8 mi)
· Sponsor: 89bio, Inc.